Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Ethiopia Launches a Covid-19 Vaccination Campaign Targeting the 12 Years and Above Population

11/29/2021 | 03:06am EST

25 November 2021, - On 16 November 2021, the Federal Ministry of Health (MoH) launched a COVID-19 vaccination campaign aiming to vaccinate people aged 12 years and above.

The Ministry has deployed over 28,000 vaccinators and more than 6.2 million doses of COVID-19 vaccines for the campaign, namely, Sinopharm, AstraZeneca, Johnson & Johnson/Janssen, and Pfizer-BioNTech. These vaccines will be used for the campaign together with vaccines that had been deployed earlier. Only Pfizer-BioNTech will be administered to the 12-18 years age group in 62 cities, while the other vaccines will be administered to those aged 18 years and older across the country in all accessible regions, zones and districts.

Speaking at a press conference to mark the beginning of the campaign, Honorable Minister of Health, Dr Liya Tadese urged the public to use this opportunity to get vaccinated to protect themselves and their families from this deadly disease.

Aiming to improve vaccine uptake, the MoH has launched a communication campaign with support from WHO Ethiopia. Through this campaign, the Ministry is transmitting information and calls to get vaccinated through short messaging system (SMS), different radio stations, and national television.

WHO Representative to Ethiopia, Dr Bouriema Hama Sambo urged, "We have the tools to stop the spread of COVID-19. Get vaccinated and adhere to the proven preventive public health measures of maintaining distance, wearing masks, keeping hands clean, and opening windows to keep spaces ventilated. He added, "WHO is committed to continue supporting the Federal Ministry of Health in the response to COVID-19 and other health emergencies."

WHO has been supporting the planning, coordination, and implementation of this COVID-19 vaccination campaign by deploying 46 technical experts for direct technical support, supervision, and monitoring. The organization has also made technical and financial contributions to the communication and demand generation activities as well as operations and logistical support to the campaign.

Several health and immunizaiton partners, namely, UNICEF, AMREF, Resolve to Save Lives Fund, Save the Children, PATH, USAID, Alive & Thrive, Clinton Health Action Initiative and Johns Hopkins University, are also supporting this campaign.

As of 24 November 2021, a total of 370,712 confirmed cases and 6,702 deaths have been reported in Ethiopia, and more than 5.4 million people have been vaccinated.

Copyright World Health Organization Africa. Distributed by AllAfrica Global Media (allAfrica.com)., source News Service English

All news about JOHNSON & JOHNSON
01/21Global Calendar For Week Ending January 28
MT
01/21CDC : Vaccines less effective against Omicron, but still reduce risk for serious illness
AQ
01/19Valneva Shares Suffer as Coronavirus Vaccine Seen Arriving Too Late
DJ
01/17Johnson & Johnson Statement on New Mexico Opioid Settlement Agreement
AQ
01/17MARKETSCREENER’S WORLD PRESS REVIEW : January 17, 2022
01/17Midatech Pharma, Janssen Extend R&D Partnership On Experimental Medicine
MT
01/14European Medicines Agency Asks AstraZeneca, Johnson & Johnson To Add Spinal Inflammatio..
MT
01/13Divco West Real Estate Services, LLC acquired 143,000 square feet, 5000 Shoreline Court..
CI
01/12Johnson & Johnson's COVID-19 Vaccine Fact Sheet Updated to Include Risk of Rare Bleedin..
MT
01/12South African Institute To Study Effects Of Pfizer, BioNTech, Johnson & Johnson Booster..
MT
More news
Analyst Recommendations on JOHNSON & JOHNSON
More recommendations
Financials (USD)
Sales 2021 94 306 M - -
Net income 2021 22 542 M - -
Net Debt 2021 596 M - -
P/E ratio 2021 19,6x
Yield 2021 2,51%
Capitalization 434 B 434 B -
EV / Sales 2021 4,61x
EV / Sales 2022 4,29x
Nbr of Employees 134 500
Free-Float 84,3%
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 164,87 $
Average target price 183,50 $
Spread / Average Target 11,3%
EPS Revisions
Managers and Directors
Joaquin Duato Chief Executive Officer & Director
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Alex Gorsky Executive Chairman
James D. Swanson Global Chief Information Officer & Executive VP
Charles O. Prince Independent Director
Sector and Competitors
1st jan.Capi. (M$)
JOHNSON & JOHNSON-3.40%434 036
ROCHE HOLDING AG-4.87%319 830
PFIZER, INC.-10.60%296 303
ABBVIE INC.-2.53%233 325
ELI LILLY AND COMPANY-11.98%220 356
NOVO NORDISK A/S-14.11%219 146